Expensify, Inc.
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
ISSUER PURCHASES OF EQUITY SECURITIES
The following table sets forth information regarding our purchases of shares of Class A common stock during the three months ended September 30, 2025.
| Total number of shares purchased · Weighted average price paid per share · Total number of shares purchased as part of publicly announced programs · Maximum number (or approximate dollar value) of shares that may yet be purchased under the program(1) | |||||
|---|---|---|---|---|---|
| July 1 - 31, 2025 | — | $— | — | $47,000,006 | |
| August 1 - 31, 2025 | 644,739 | $1.84 | 644,739 | $45,814,194 | |
| September 1 - 30, 2025 | 935,024 | $1.94 | 935,024 | $44,000,006 | |
| Three months ended September 30, 2025 | 1,579,763 | 1,579,763 | |||
(1)On February 27, 2025, we announced the approval of a share repurchase program with authorization to purchase up to $50.0 million of our Class A common stock at management’s discretion that expires on March 31, 2028, does not obligate us to repurchase any specific number of shares and may be modified, suspended or terminated at any time at our discretion. As of September 30, 2025, we had $44.0 million remaining under the share repurchase authorization.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.